Stay updated with breaking news from Wray Mcdermott. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Approved with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations Approval for
:quality(70):focal(1695x1651:1705x1661)/cloudfront-eu-central-1.images.arcpublishing.com/irishtimes/HCRIH3IT6RQ4YTSHF4HXQ2HK4I.jpg)
Cancer medicine is undergoing a revolution, with scores of new treatments targeting specific tumours coming on stream
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/irishtimes/QVC27F2JOFJKXIF35P6IYJVMOA.jpg)
Public patients may now have to wait up to two years longer than all private patients for access to innovative therapies
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/irishtimes/D6BVN4ESRFEQFFTZGNZZHFT77Y.jpg)
Laya Healthcare and Irish Life Health must be unsettled as leading oncologists clearly direct patients to rival VHI
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/irishtimes/MIHGU3Y4UJEOZHVLR4OPZKWYYE.JPG)
Two cancer patients and two oncologists raise concerns about how customers of private health insurers Irish Life and Laya Healthcare are losing out on access to new cancer treatments